Skip navigation

Refine by Type

Results 1 - 7 of 7 for AXITINIB
  1. Axitinib is used to treat advanced renal cell carcinoma (RCC, a type of cancer that begins in ... have not been treated successfully with another medication. Axitinib is in a class of medications called kinase ...
  2. Targeted Therapies for Kidney Cancer (American Cancer Society)  
    ... tests to check for liver or other problems. Axitinib (Inlyta ® ) Axitinib also inhibits several tyrosine kinases, including some that ... at least one other treatment has been tried. Axitinib is taken as a pill twice a day. ...
  3. ... Sutent ® ), pazopanib (Votrient ® ), cabozantinib (Cometriq), motesanib (AMG 706), axitinib (Inlyta ® ), and vandetanib (Caprelsa ® ). Vandetanib and cabozantinib are ... Some of the TKIs listed above, such as axitinib, motesanib, sunitinib, sorafenib, pazopanib, and cabozantinib, have anti- ...
  4. Cancer Drug Information From the National Institutes of Health (National Cancer Institute)  
    ... Trioxide Arzerra (Ofatumumab) Asparaginase Erwinia chrysanthemi Avastin (Bevacizumab) Axitinib Azacitidine Back to Top B BEACOPP Becenum (Carmustine) ... Ifosfamidum (Ifosfamide) Imatinib Mesylate Imbruvica (Ibrutinib) Imiquimod Inlyta (Axitinib) Intron A (Recombinant Interferon Alfa-2b) Iodine 131 ...
  5. ... of these drugs include bevacizumab (Avastin ® ), pazopanib (Votrient ® ), axitinib (Inlyta ® ), and cabozantinib (Cometriq TM ). Researchers are also ...
  6. Targeted Cancer Therapies From the National Institutes of Health (National Cancer Institute)  
    ... sunitinib (Sutent®) , pazopanib (Votrient®) , temsirolimus (Torisel®) , everolimus (Afinitor®) , axitinib (Inlyta®) Leukemia: Tretinoin (Vesanoid®) , imatinib mesylate (Gleevec®) , dasatinib ( ...
  7. Drugs Approved for Kidney (Renal Cell) Cancer From the National Institutes of Health (National Cancer Institute)  
    This page lists cancer drugs approved by the Food and Drug Administration (FDA) for kidney (renal cell) cancer. The list includes generic names and brand names. ...